BIOMAT Database Logo BIOMAT Database Logo

[Physiopathologic bases of diagnosis and treatment of primary hyperaldosteronism]. 1970

J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
[Diagnosis and treatment of primary hyperaldosteronism].
January 2004, Khirurgiia,
J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
Diagnosis and treatment of primary hyperaldosteronism.
December 1994, Annals of internal medicine,
J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
[Physiopathologic bases of arthrosis treatment].
April 1980, Revue medicale de Liege,
J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
[Diagnosis and surgical treatment of primary hyperaldosteronism].
January 2002, Khirurgiia,
J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
[Physiopathologic bases of diagnosis of asthma and emphysema].
March 1969, Maroc medical,
J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
[Physiopathologic bases of the diagnosis of jaundice].
November 1973, Revista espanola de las enfermedades del aparato digestivo,
J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
[Physiopathologic bases of treatment of shock].
March 1971, Laval medical,
J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
[Clinical course, diagnosis and treatment of primary hyperaldosteronism].
March 1974, Klinicheskaia meditsina,
J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
[Physiopathologic bases of the treatment of uremia].
January 1956, Anales. Universidad Nacional Mayor de San Marcos. Facultad de Medicina,
J Menard, and B Weil, and M Safar, and J P Fendler, and J C Legrand, and P Meyer, and J Vaysse, and P Milliez
[Physiopathologic bases of treatment of portacaval encephalopathy].
February 1971, Acta gastro-enterologica Belgica,
Copied contents to your clipboard!